Date published: 2026-4-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

MLH1 Inhibitors

MLH1 inhibitors constitute a diverse array of compounds that intricately modulate MLH1 expression, directly or indirectly impacting DNA mismatch repair processes. These chemicals operate through distinct biochemical mechanisms, contributing to the intricate regulation of MLH1 and its role in maintaining genomic stability. One group of inhibitors, such as Curcumin, targets the NF-κB pathway, suppressing IκB kinase and influencing MLH1 expression. This direct modulation illustrates the interconnectedness of inflammatory signaling pathways and the regulation of DNA repair mechanisms. Another set of inhibitors, exemplified by Trichostatin A and 5-Aza-2'-deoxycytidine, operates indirectly by modifying chromatin structure. Trichostatin A inhibits histone deacetylases, impacting the acetylation status of histones and potentially influencing MLH1 expression. On the other hand, 5-Aza-2'-deoxycytidine induces DNA demethylation, offering an epigenetic route for the regulation of MLH1. These compounds highlight the significance of epigenetic modifications in shaping the landscape of DNA repair processes. Compounds like Cisplatin and Etoposide induce DNA damage, triggering a cellular response that indirectly impacts MLH1. These agents play a role in the DNA damage response pathway, where MLH1 is involved in rectifying DNA mismatches arising from damaged DNA. Sulindac provides a unique link between inflammatory signaling and MLH1 regulation by inhibiting the Wnt/β-catenin pathway. This connection underscores the intricate interplay between inflammation and DNA repair processes. Moreover, 6-Mercaptopurine, by interfering with purine metabolism, and Valproic Acid, through epigenetic modulation, offer alternative avenues for MLH1 regulation. Camptothecin, a topoisomerase I inhibitor, also indirectly influences MLH1 by promoting DNA damage. This diverse array of MLH1 inhibitors reflects the multifaceted strategies employed to modulate DNA mismatch repair processes, providing valuable insights into potential avenues for intervention in the context of DNA repair and genomic stability. Researchers can leverage this diverse toolkit to gain a comprehensive understanding of MLH1 regulation and its implications for cellular homeostasis.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid indirectly inhibits MLH1 by targeting histone deacetylases (HDACs). It promotes histone acetylation, impacting chromatin structure and gene expression. MLH1, sensitive to epigenetic modifications, can experience altered transcription in response to valproic acid. The compound's influence on HDACs provides a mechanism for epigenetic modulation of MLH1 expression.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin indirectly influences MLH1 by inducing DNA damage. As a topoisomerase I inhibitor, it promotes DNA strand breaks, activating DNA damage response pathways. MLH1 expression can be modulated as part of the cellular response to DNA damage. Camptothecin's impact on DNA integrity may contribute to alterations in MLH1 levels, affecting DNA mismatch repair processes.